Works matching IS 00099236 AND DT 2003 AND VI 74 AND IP 1
Results: 15
Predicting 'real world' effectiveness by integrating adherence with pharmacodynamic modeling.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 1, doi. 10.1016/S0009-9236(03)00091-2
- By:
- Publication type:
- Article
Intra-arterial vasopressin in the human forearm: pharmacodynamics and the role of nitric oxide<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 9, doi. 10.1016/S0009-9236(03)00065-1
- By:
- Publication type:
- Article
Effects of the neurokinin<sub>1</sub> receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 17, doi. 10.1016/S0009-9236(03)00066-3
- By:
- Publication type:
- Article
Effect of fluconazole on the pharmacokinetics and pharmacodynamics of nateglinide<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 25, doi. 10.1016/S0009-9236(03)00089-4
- By:
- Publication type:
- Article
Artemisinin autoinduction is caused by involvement of cytochrome P450 2B6 but not 2C9.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 32, doi. 10.1016/S0009-9236(03)00092-4
- By:
- Publication type:
- Article
β<sub>1</sub>-Adrenergic Receptor Polymorphisms and Antihypertensive Response to Metoprolol<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 44, doi. 10.1016/S0009-9236(03)00068-7
- By:
- Publication type:
- Article
Effect of the C825T Polymorphism of the G Protein β3 Subunit on the Systolic Blood Pressure-Lowering Effect of Clonidine in Young, Healthy Male Subjects<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 53, doi. 10.1016/S0009-9236(03)00087-0
- By:
- Publication type:
- Article
Acenocoumarol Pharmacokinetics in Relation to Cytochrome P450 2C9 Genotype.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 61, doi. 10.1016/S0009-9236(03)00088-2
- By:
- Publication type:
- Article
Effects of polymorphism in Promoter Region of Human CYP2A6 Gene (CYP2A6*9) on Expression Level of Messenger Ribonucleic Acid and Enzymatic Activity In Vivo and In Vitro*.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 69, doi. 10.1016/S0009-9236(03)00090-0
- By:
- Publication type:
- Article
Effect of 2 Weeks of Theophylline on Glucose Counterregulation in Patients with Type 1 Diabetes and Unawareness of Hypoglycemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 77, doi. 10.1016/S0009-9236(03)00093-6
- By:
- Publication type:
- Article
Pharmacokinetics of anakinra in subjects with different levels of renal function<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 85, doi. 10.1016/S0009-9236(03)00094-8
- By:
- Publication type:
- Article
Effects of willow bark extract and therapeutic activity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 95, doi. 10.1016/S0009-9236(03)00115-2
- By:
- Publication type:
- Article
Anti-inflammatory effects of willow bark extract.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 96, doi. 10.1016/S0009-9236(03)00116-4
- By:
- Publication type:
- Article
Reply: effects of willow bark extract.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 96, doi. 10.1016/S0009-9236(03)00117-6
- By:
- Publication type:
- Article
Good Publication Practice guidelines for clinical trials?
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 97, doi. 10.1016/S0009-9236(03)00119-X
- By:
- Publication type:
- Article